comparemela.com

Page 11 - New England Journal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novel Glucagon/GLP-1 Receptor Dual Agonist Improved MASH in Phase II Study

Effects may be related to weight loss, not changes in fibrogenesis, expert suggests

Ozempic may help fight kidney disease, study finds

As chronic kidney disease rises nationwide, a new study partially conducted in Orlando suggests weight loss drugs like Ozempic and Wegovy could be part of the solution.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.